Northrop Grumman SEC Filings

Northrop Grumman (NOC) filed a Form 144 disclosing a proposed sale of 192 shares of its common stock. The shares are expected to be sold through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $108,931.20 based on the price used in the notice. These shares were acquired through an RSU vesting transaction from the issuer on 05/15/2025 as compensation.

The filing notes that 142,720,067 shares of common stock were outstanding for the issuer, providing context for the size of this intended sale. The approximate date of sale listed is 11/24/2025. The person on whose behalf the shares are to be sold must represent that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Northrop Grumman (NOC) announced a CFO transition. The Board elected John Greene, age 60, as corporate vice president and chief financial officer, effective January 7, 2026. Greene previously served as EVP and CFO of Discover Financial Services from September 2019 to May 2025, and held senior finance roles at Bioverativ, Willis Group, HSBC, and General Electric.

Kenneth Crews will step down as CFO effective January 7, 2026 and remain with the company in an advisory capacity until February 20, 2026 to support a smooth transition. The Compensation and Human Capital Committee approved a base salary for Greene of $955,000 and a sign-on grant of Restricted Stock Rights valued at $2,000,000, with additional annual and long-term incentives commensurate with the role.

The company issued a press release on November 6, 2025 and reaffirmed its previously announced fiscal year 2025 guidance.

Northrop Grumman (NOC) reported Q3 2025 results with total sales of $10.423 billion, up modestly year over year, and diluted EPS of $7.67. Operating income was $1.242 billion as product sales rose, while service sales were steady. Segment performance was mixed: Mission Systems and Defense Systems grew operating income, while Aeronautics Systems and Space Systems faced program‑mix and cost dynamics.

The company recorded net EAC adjustments that included a $122 million unfavorable change on early B‑21 LRIP lots, largely offset by a loss contingency reduction tied to a contract restructure, and a $68 million favorable adjustment in restricted microelectronics. Year to date included a $231 million gain on the divestiture of training services. Backlog was $91.4 billion, with 40% expected as revenue over the next 12 months. Cash from operations was $860 million year to date, after working capital use on receivables and unbilled balances. The quarterly dividend increased 12% to $2.31 per share, and share repurchases totaled $1.168 billion year to date. As of October 16, 2025, 142,720,067 common shares were outstanding.

Northrop Grumman Corporation furnished a Form 8-K under Item 2.02 to announce it issued an earnings release for the quarter ended September 30, 2025. The earnings release is furnished as Exhibit 99.

Marianne C. Brown, a director of Northrop Grumman Corporation (NOC), reported an internal acquisition on 09/30/2025. The Form 4 shows an acquisition of 76 shares of common stock deferred into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan at a reported price of $609.32 per share. Following the transaction she beneficially owns 10,836 shares directly. The filing states the 76 shares represent a deferral into a stock unit account exempt under Rule 16b-3, and notes dividends in the stock unit account are exempt and not reportable under Rule 16a-11. The form was signed by an attorney-in-fact on 10/01/2025.

Krishna Arvind, a director of Northrop Grumman Corporation (NOC), reported a transaction dated 09/30/2025 on SEC Form 4. The filing shows 59 shares of common stock were acquired at a price of $609.32 by deferring shares into a stock unit account under the Northrop Grumman 2024 Long-Term Incentive Stock Plan, a transaction treated as exempt under Rule 16b-3. Following the transaction, the reporting person beneficially owned 2,184 shares in the stock unit account, which includes dividends credited to that account. The form was signed by an attorney-in-fact on behalf of the reporting person on 10/01/2025. The filing is a routine director stock deferral into a company long-term incentive plan.

Northrop Grumman Corporation entered into a credit agreement dated September 2, 2025 that provides a five-year senior unsecured revolving credit facility with an aggregate principal amount of $3.0 billion. This Revolving Credit Facility replaces the companys prior five-year revolving credit facility of $2.5 billion entered into on August 23, 2022.

The filing states the Revolving Credit Facility is intended to support the companys commercial paper program and other general corporate purposes. JPMorgan Chase Bank, N.A. serves as administrative agent and the agreement is among Northrop Grumman, the lenders party thereto, and the administrative agent.

Capital International Investors reports beneficial ownership of 12,385,281 shares of Northrop Grumman Corporation common stock, equal to 8.6% of 143,928,185 shares believed outstanding. The filing is a Schedule 13G (Amendment No. 8) for CUSIP 666807102 and shows sole voting power for 12,218,846 shares and sole dispositive power for 12,385,281 shares.

The filing includes a certification that the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The statement is signed by Jae Won Chung, Vice President and Senior Counsel II, Capital Research and Management Company, dated 08/12/2025.